L860-0134 Screening compound: 3-({[(4-chloro-2-methoxy-5-methylphenyl)carbamoyl]methyl}sulfanyl)-N-(3-methylphenyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide

L860-0134 Screening compound: 3-({[(4-chloro-2-methoxy-5-methylphenyl)carbamoyl]methyl}sulfanyl)-N-(3-methylphenyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide
L860-0134 Screening compound: 3-({[(4-chloro-2-methoxy-5-methylphenyl)carbamoyl]methyl}sulfanyl)-N-(3-methylphenyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L860-0134
3-({[(4-chloro-2-methoxy-5-methylphenyl)carbamoyl]methyl}sulfanyl)-N-(3-methylphenyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L860-0134

Molecular Formula

C24H22ClN5O3S (C24 H22 ClN5 O3 S)

Compound Name

3-({[(4-chloro-2-methoxy-5-methylphenyl)carbamoyl]methyl}sulfanyl)-N-(3-methylphenyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide

IUPAC name

3-({[(4-chloro-2-methoxy-5-methylphenyl)carbamoyl]methyl}sulfanyl)-N-(3-methylphenyl)-[124]triazolo[43-a]pyridine-6-carboxamide

SMILES

Cc1cccc(NC(c2cn3c(SCC(Nc(c(OC)c4)cc(C)c4Cl)=O)nnc3cc2)=O)c1

InChI

InChI=1S/C24H22ClN5O3S/c1-14-5-4-6-17(9-14)26-23(32)16-7-8-21-28-29-24(30(21)12-16)34-13-22(31)27-19-10-15(2)18(25)11-20(19)33-3/h4-12H,13H2,1-3H3,(H,26,32)(H,27,31)

InChI Key

HQIVJDKDMVBMQB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27481459

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.99

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.671

Distribution Coefficient, logD

4.669

Water Solubility, LogSw

-4.90

Polar Surface Area

75.225

Acid Dissociation Constant (pKa)

9.76

Base Dissociation Constant (pKb)

-0.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

L860-0134 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L860-0134 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L860-0134?
Check Price and Availability of L860-0134, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L860-0134 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L860-0134
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L860-0134
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L860-0134 available by request